Miami, Florida, United States The main department of described VC is located in the Miami. The venture was found in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Arvelle Therapeutics, On Target Laboratories, NeuWave Medical. Among the most popular fund investment industries, there are Pharmaceutical, Medical Device. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
This organization was formed by Sami Mnaymneh, Tony Tamer. Besides them, we counted 5 critical employees of this fund in our database.
Considering the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations. This H.I.G. BioHealth Partners works on 11 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2016. The fund is generally included in 2-6 deals every year.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the H.I.G. BioHealth Partners, startups are often financed by Quaker Partners, New Enterprise Associates, MPM Capital. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Versant Ventures, Quaker Partners. In the next rounds fund is usually obtained by Quaker Partners, New Enterprise Associates, OUP (Osage University Partners).
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aesop Capital | California, San Francisco, United States |
| Enabling Technology Fund B.V. | - |
| Foton Daimler Automotive | Beijing, China, Huairou |
| Jemison Investment Company | Alabama, Birmingham, United States |
| John Nurminen Oy | Finland, Helsinki, Southern Finland |
| Lloyd's Lab | England, London, United Kingdom |
| MAN Truck & Bus | Bayern, Germany, Munich |
| Miyazaki Taiyo Capital | Japan, Miyazaki, Miyazaki Prefecture |
| Neurato Investments | - |
| Omega Funds | Boston, Massachusetts, United States |
| Paribas Deelnemingen | - |
| Pepper Media Holding | Berlin, Berlin, Germany |
| SDG Invest | - |
| Shenzhen Qianhai Huaye Yuan Touzi | China, Guangdong, Shenzhen |
| TrustCapital | India, Maharashtra, Mumbai |
| Ufi Ventures | England, London, United Kingdom |
| Zhongshan Qingqi Chuangtou | Anhui, China, Zhongshan |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Click Therapeutics | $52M | 22 Oct 2021 | New York, New York, United States | ||
Arvelle Therapeutics | $42M | 27 May 2020 | Basel, Basel-City, Switzerland | ||
Zerigo Health | $18M | 23 Oct 2019 | San Diego, California, United States | ||
Arvelle Therapeutics | $196M | 18 Feb 2019 | Basel, Basel-City, Switzerland | ||
Neurana Pharmaceuticals | $60M | 08 May 2018 | San Diego, California, United States | ||
Intact Vascular | $20M | 16 Apr 2018 | Radnor Township, Pennsylvania, United States | ||
On Target Laboratories | $4M | 14 Mar 2018 | Illinois, United States | ||
Intact Vascular | $7M | 03 Jan 2017 | Radnor Township, Pennsylvania, United States | ||
Iconic Therapeutics | $10M | 09 Aug 2016 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Click Therapeutics | $52M | 22 Oct 2021 | New York, New York, United States | ||
Arvelle Therapeutics | $42M | 27 May 2020 | Basel, Basel-City, Switzerland | ||
Zerigo Health | $18M | 23 Oct 2019 | San Diego, California, United States | ||
Arvelle Therapeutics | $196M | 18 Feb 2019 | Basel, Basel-City, Switzerland | ||
Neurana Pharmaceuticals | $60M | 08 May 2018 | San Diego, California, United States | ||
Intact Vascular | $20M | 16 Apr 2018 | Radnor Township, Pennsylvania, United States | ||
On Target Laboratories | $4M | 14 Mar 2018 | Illinois, United States | ||
Intact Vascular | $7M | 03 Jan 2017 | Radnor Township, Pennsylvania, United States | ||
Iconic Therapeutics | $10M | 09 Aug 2016 | South San Francisco, California, United States |
